Impact of Recent Developments in Lung Cancer on the Practice of Pathology.
Abstract
Landmark events in the field of lung cancer in the past year have the potential to significantly alter the practice of pathology. Three key events are (1) approval of payment for low-dose computed tomography screening for lung cancer, (2) publication of an extensively revised World Health Organization classification of lung cancers, and (3) approval of immunohistochemistry based companion diagnostics by the US Food and Drug Administration. We briefly review these milestones in the context of their impact on the practice of pathology.
我要评论
翻译外文期刊杂志的文章摘要，通过管理员审核者可获取相应积分
本期排行
- Acute Lung Injury: A Clinical ...
- Next-Generation Sequencing of ...
- Atypical Fibroxanthoma.
- Programmed Death Ligand-1 Immu...
- PD-L1 and Lung Cancer: The Era...
- New Markers for Separating Ben...
- Transbronchial Cryobiopsies in...
- Ribonucleic Acid In Situ Hybri...
- Impact of Recent Developments ...
- Review of Telemicrobiology.
共0条评论